170 related articles for article (PubMed ID: 33981594)
1. The Role of Adjuvant Chemotherapy in Metaplastic Breast Carcinoma: A Competing Risk Analysis of the SEER Database.
Lan T; Lu Y; Zheng R; Shao X; Luo H; He J; Yang H; Xu H; Wang X; Hu Z
Front Oncol; 2021; 11():572230. PubMed ID: 33981594
[No Abstract] [Full Text] [Related]
2. Research on the Role of Combined Chemotherapy and Radiotherapy in Patients With N+ Non-Metastatic Metaplastic Breast Carcinoma: A Competing Risk Analysis Model Based on the SEER database, 2000 to 2015.
Ma Y; Yang Z; Gao Y; Li K; Qiu P; Chen H; Pu S; Wang B; Zhou C
Front Oncol; 2020; 10():583488. PubMed ID: 33552959
[TBL] [Abstract][Full Text] [Related]
3. Nomogram Predicting Cause-Specific Mortality in Nonmetastatic Male Breast Cancer: A Competing Risk Analysis.
Sun W; Cheng M; Zhou H; Huang W; Qiu Z
J Cancer; 2019; 10(3):583-593. PubMed ID: 30719155
[No Abstract] [Full Text] [Related]
4. Presentation and survival by hormonal receptor status in metaplastic breast cancer: A propensity score-matched analysis.
Wang S; Hu J; Zhang Y; Shen J; Dong F; Zhang X; Lu C; Shang D
Breast; 2021 Dec; 60():168-176. PubMed ID: 34653726
[TBL] [Abstract][Full Text] [Related]
5. A Competing Nomogram to Predict Survival Outcomes in Invasive Micropapillary Breast Cancer.
Li D; Zhong C; Cheng Y; Zhu N; Tan Y; Zhu L; Xu D; Yuan Y
J Cancer; 2019; 10(27):6801-6812. PubMed ID: 31839814
[No Abstract] [Full Text] [Related]
6. Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database.
McMurtry V; Cleary AS; Ruano AL; Lomo L; Gulbahce HE
Am J Clin Oncol; 2023 Dec; 46(12):559-566. PubMed ID: 37705411
[TBL] [Abstract][Full Text] [Related]
7. Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.
Fu J; Wu L; Jiang M; Li D; Jiang T; Hong Z; Wang F; Li S
PLoS One; 2016; 11(10):e0164921. PubMed ID: 27760180
[TBL] [Abstract][Full Text] [Related]
8. Nomogram Predicts the Role of Contralateral Prophylactic Mastectomy in Male Patients With Unilateral Breast Cancer Based on SEER Database: A Competing Risk Analysis.
Li K; Wang B; Yang Z; Yu R; Chen H; Li Y; He J; Zhou C
Front Oncol; 2021; 11():587797. PubMed ID: 33996535
[TBL] [Abstract][Full Text] [Related]
9. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
10. Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer.
Zhu J; Zheng H; Ge C; Lin H; Yu K; Wu L; Li D; Zhou S; Tang W; Wang Q; Zhang X; Jin X; Xu X; Du J; Fu J
Clin Breast Cancer; 2022 Apr; 22(3):e296-e309. PubMed ID: 34627728
[TBL] [Abstract][Full Text] [Related]
11. The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database.
Li Y; Chen M; Pardini B; Dragomir MP; Lucci A; Calin GA
J Transl Med; 2019 Sep; 17(1):318. PubMed ID: 31547814
[TBL] [Abstract][Full Text] [Related]
12. Hormone Receptor Status May Impact the Survival Benefit Between Medullary Breast Carcinoma and Atypical Medullary Carcinoma of the Breast: A Population-Based Study.
Qin W; Qi F; Guo M; Wang L; Zang YS
Front Oncol; 2021; 11():677207. PubMed ID: 34295817
[TBL] [Abstract][Full Text] [Related]
13. The role of chemotherapy in patients with T1bN0M0 triple-negative breast cancer: a real-world competing risk analysis.
Lan T; Lu Y; Luo H; Yang O; He J; Xu H; Hu Z
J Cancer; 2021; 12(1):10-17. PubMed ID: 33391398
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Analysis of Primary Breast Signet Ring Cell Carcinoma and Mucinous Breast Adenocarcinoma: A SEER Population-Based Study.
Wang S; Zhang Y; Yin F; Zhang X; Yang Z; Wang X
Front Oncol; 2021; 11():783631. PubMed ID: 34956901
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Post-Mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: A Propensity Score-Matched Analysis of the SEER Database.
Hu J; Tan J; Dong F; Zhang X; Ming J; Huang T
Front Oncol; 2021; 11():593121. PubMed ID: 35096554
[TBL] [Abstract][Full Text] [Related]
16. Research on Effectiveness of Prior Cancer on Survival Outcomes for Patients with Nonmetastatic Triple-Negative Breast Cancer: A Competing Risk Analysis and Propensity Score Matching Analysis of the SEER Database.
Chen H; Yan L; Pu S; Zhu L; Zhang H; Zhou C
J Oncol; 2021; 2021():9988624. PubMed ID: 34580591
[TBL] [Abstract][Full Text] [Related]
17. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
Li Y; Zhang N; Zhang H; Yang Q
J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
[TBL] [Abstract][Full Text] [Related]
18. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
[TBL] [Abstract][Full Text] [Related]
19. Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer.
Wang Y; Chen K; Yang Y; Tan L; Chen L; Zhu L; Su F; Liu X; Li S
Ann Transl Med; 2019 Oct; 7(20):536. PubMed ID: 31807518
[TBL] [Abstract][Full Text] [Related]
20. The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma.
Wu SG; Yang SP; Zhang WW; Wang J; Lian CL; Chen YX; He ZY
Sci Rep; 2020 Dec; 10(1):22070. PubMed ID: 33328559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
